Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ardern-Jones

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Pharmacogenetics|July 4, 2001
Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancerZ Kote-Jarai, D Easton, S M Edwards, et al.
Prostate Cancer and Prostatic Diseases|February 16, 2005
Association between hormonal genetic polymorphisms and early-onset prostate cancerM S Forrest, S M Edwards, R Houlston, et al.
International Journal of Cancer|September 30, 1999
Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survivalS M Edwards, M D Badzioch, R Minter, et al.
International Journal of Cancer|September 2, 1998
Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study CollaboratorsS M Edwards, W D Dunsmuir, C E Gillett, et al.
British Journal of Cancer|July 29, 2004
ATM polymorphisms as risk factors for prostate cancer developmentS Angèle, A Falconer, S M Edwards, et al.
Journal of Medical Genetics|May 18, 2010
The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers--implications for oncogenetics practiceE K Bancroft, I Locke, A Ardern-Jones, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
High risk genes predisposing to prostate cancer development-do they exist?R Singh, R A Eeles, F Durocher, et al.
Cancer Research|September 2, 2000
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study CollaboratorsS A Gayther, K A de Foy, P Harrington, et al.
American Journal of Human Genetics|April 29, 1998
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study CollaboratorsR A Eeles, F Durocher, S Edwards, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pharmacogenetics|July 4, 2001
Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancerZ Kote-Jarai, D Easton, S M Edwards, et al.
Prostate Cancer and Prostatic Diseases|February 16, 2005
Association between hormonal genetic polymorphisms and early-onset prostate cancerM S Forrest, S M Edwards, R Houlston, et al.
International Journal of Cancer|September 30, 1999
Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survivalS M Edwards, M D Badzioch, R Minter, et al.
International Journal of Cancer|September 2, 1998
Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study CollaboratorsS M Edwards, W D Dunsmuir, C E Gillett, et al.
British Journal of Cancer|July 29, 2004
ATM polymorphisms as risk factors for prostate cancer developmentS Angèle, A Falconer, S M Edwards, et al.
Journal of Medical Genetics|May 18, 2010
The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers--implications for oncogenetics practiceE K Bancroft, I Locke, A Ardern-Jones, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
High risk genes predisposing to prostate cancer development-do they exist?R Singh, R A Eeles, F Durocher, et al.
Cancer Research|September 2, 2000
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study CollaboratorsS A Gayther, K A de Foy, P Harrington, et al.
American Journal of Human Genetics|April 29, 1998
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study CollaboratorsR A Eeles, F Durocher, S Edwards, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 3